John E. Macor

6.2k citations

212 papers · 5.1k · h-index 36

Impact in

Organic Chemistry top 1%
- Synthesis and biological activity
Cellular and Molecular Neuroscience top 2%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research

Papers in

Organic Chemistry 89
- Synthesis and biological activity 38
- Synthesis of Indole Derivatives 27
Cellular and Molecular Neuroscience 50
- Neuropeptides and Animal Physiology 24
- Neurotransmitter Receptor Influence on Behavior 19
- Neuroscience and Neuropharmacology Research 15

Co-authors: Edward Curtis Taylor (6 shared papers)Kevin Ryan (15 shared papers)Edward Curtis Taylor (4 shared papers)Gene M. Dubowchik (30 shared papers)B. Kenneth Koe (10 shared papers)Jann A. Nielsen (3 shared papers)James H. Heym (3 shared papers)Ronald J. Post (11 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (62 papers)Journal of Medicinal Chemistry (33 papers)Tetrahedron Letters (24 papers)ACS Medicinal Chemistry Letters (16 papers)The Journal of Organic Chemistry (11 papers)
Partner nations: United States India Germany

In The Last Decade

John E. Macor

212 papers receiving 4.7k citations

Peers

Countries citing papers authored by John E. Macor

Since Specialization

Citations

This map shows the geographic impact of John E. Macor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Macor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Macor more than expected).

Fields of papers citing papers by John E. Macor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Macor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Macor. The network helps show where John E. Macor may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Macor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Macor Line = papers co-authored together John E. Macor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor ACS Medicinal Chemistry Letters ·Kevin W. Gillman, John E. Starrett, Michael F. Parker, Kai Ming Xie, Joanne J. Bronson, Lawrence R. Marcin, Kate E. McElhone, Carl P. Bergstrom	2010	162
2	The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist Bioorganic & Medicinal Chemistry Letters ·John E. Macor, David A. Gurley, Thomas H. Lanthorn, James T. Loch, Robert A. Mack, GEORGE B. MULLEN, Oahn Tran, John C. Gordon +1 other	2001	148
3	3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1) agonist and rotationally restricted phenolic analog of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole Journal of Medicinal Chemistry* ·John E. Macor, James H. Heym, Jeffrey L. Ives, Lorraine A. Lebel, Jann A. Nielsen, Kevin Ryan, David W. Schulz +2 others	1990	146
4	(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘-oxazolidin-2‘-one], a Conformationally Restricted Analogue of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor Journal of Medicinal Chemistry ·GEORGE B. MULLEN, James J. Napier, Michael Balestra, Thomas R. DeCory, John E. Macor, Robert A. Mack, James T. Loch, Edward X. Wu	2000	118
5	Enantioselective Synthesis of a Highly Potent Selective Serotonin Reuptake Inhibitor. An Application of Imidazolidinone Catalysis to the Alkylation of Indoles with an α,β-Disubstituted α,β-Unsaturated Aldehyde Organic Letters ·Dalton King, Zhaoxing Meng, Derek J. Denhart, Ronald J. Mattson, Roy Kimura, Dedong Wu, Qi Gao, John E. Macor	2005	109
6	Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core Bioorganic & Medicinal Chemistry Letters ·Prasanna Sivaprakasam, Xiaojun Han, Rita L. Civiello, Swanee Jacutin-Porte, Kevin Kish, Matt E. Pokross, Hal A. Lewis, Nazia Ahmed	2015	109
7	Biochemical and behavioral studies of the 5‐HT1B receptor agonist, CP‐94,253 Drug Development Research ·B. Kenneth Koe, Jann A. Nielsen, John E. Macor, James H. Heym	1992	103
8	Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer’s Mouse Phenotypes Cell Reports ·Laura T. Haas, Santiago V. Salazar, Levi M. Smith, Helen R. Zhao, Timothy O. Cox, Charlotte S. Herber, Andrew P. Degnan, Anand Balakrishnan	2017	91
9	Discovery of (5 S ,6 S ,9 R )-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5 H -cyclohepta[ b ]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1 H -imidazo[4,5- b ]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine Journal of Medicinal Chemistry ·Guanglin Luo, Ling Chen, Charles M. Conway, Rex Denton, Deborah Keavy, Laura J. Signor, Walter A. Kostich, Kimberley A. Lentz	2012	79
10	Dual Angiotensin II and Endothelin A Receptor Antagonists: Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics Journal of Medicinal Chemistry ·Natesan Murugesan, Zhengxiang Gu, Leena Fadnis, John E. Tellew, Rose Ann F. Baska, Yifan Yang, Sophie M. Beyer, Hossain Monshizadegan	2004	77
11	Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain Journal of Pharmacology and Experimental Therapeutics ·Walter A. Kostich, Brian D. Hamman, Kumaran Dandapani, Jianlin Feng, Amy E. Easton, Clotilde Bourin, Kevin B. Baker, Katerina V. Savelieva	2016	72
12	Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors Journal of Medicinal Chemistry ·Guanglin Luo, Ling Chen, Catherine R. Burton, Prasanna Sivaprakasam, Carol Krause, Yang Cao, Nengyin Liu, Jonathan Lippy	2016	66
13	Intramolecular diels-alder reactions of 1,2,4-triazines. Tetrahedron ·Edward Curtis Taylor, John E. Macor, Joseph L. Pont	1987	65
14	Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2 Journal of Medicinal Chemistry ·Chunjian Liu, James C. Lin, Charles M. Langevine, Daniel Smith, Jianqing Li, John S. Tokarski, Javed Khan, Max Ruzanov	2020	64
15	Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat Journal of Pharmacology and Experimental Therapeutics ·Charles F. Albright, Randy C. Dockens, Jere E. Meredith, Richard E. Olson, Randy Slemmon, Kimberley A. Lentz, Rex Denton, Gary D. Pilcher	2012	60
16	The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression Journal of Biological Chemistry ·Catherine R. Burton, Jere E. Meredith, Donna M. Barten, Margi E. Goldstein, Carol Krause, Cathy J. Kieras, Lisa M. Sisk, Lawrence G. Iben	2008	58
17	Discovery of (R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): A Potent Antagonist of the Human Calcitonin Gene-Related Peptide Receptor for Migraine with Rapid and Efficient Intranasal Exposure Journal of Medicinal Chemistry ·Andrew P. Degnan, Prasad V. Chaturvedula, Charles M. Conway, Deborah A. Cook, Carl D. Davis, Rex Denton, Xiaojun Han, Robert Macci	2008	57
18	Discovery of Tyrosine-Based Potent and Selective Melanocortin-1 Receptor Small-Molecule Agonists with Anti-inflammatory Properties Journal of Medicinal Chemistry ·Timothy F. Herpin, Guixue Yu, Kenneth E. Carlson, George C. Morton, Ximao Wu, Liya Kang, Huji Tuerdi, Ashish Khanna	2003	54
19	Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase Bioorganic & Medicinal Chemistry Letters ·David S. Weinstein, Wen Liu, Zhengxiang Gu, Charles M. Langevine, Khehyong Ngu, Leena Fadnis, Donald W. Combs, Doree F. Sitkoff	2005	51
20	Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): A potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery Bioorganic & Medicinal Chemistry Letters ·Prasad V. Chaturvedula, Stephen E. Mercer, Sokhom S. Pin, George P. Thalody, Cen Xu, Charlie M. Conway, Deborah Keavy, Laura J. Signor	2013	51

About John E. Macor

John E. Macor is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience, Physiology, Molecular Biology and Pharmacology, having authored 212 papers that have together received 5.1k indexed citations. Recurring topics across this work include Synthesis and biological activity (38 papers), Alzheimer's disease research and treatments (30 papers), Synthesis of Indole Derivatives (27 papers), Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (23 papers), Neurotransmitter Receptor Influence on Behavior (19 papers), Migraine and Headache Studies (17 papers) and Neuroscience and Neuropharmacology Research (15 papers). The work is most often cited by research in Organic Chemistry (1.8k citations), Cellular and Molecular Neuroscience (639 citations), Physiology (762 citations), Computational Theory and Mathematics (358 citations) and Psychiatry and Mental health (362 citations). John E. Macor has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Edward Curtis Taylor, Kevin Ryan, Edward Curtis Taylor, Gene M. Dubowchik, B. Kenneth Koe, Jann A. Nielsen, James H. Heym, Ronald J. Post, Lorraine A. Lebel and Robert A. Mack. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, ACS Medicinal Chemistry Letters and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John E. Macor

Impact in

Papers in i

In The Last Decade

John E. Macor

Peers

Countries citing papers authored by John E. Macor

Fields of papers citing papers by John E. Macor

All Works

About John E. Macor

Explore authors with similar magnitude of impact

Papers in